Home > Financial Ratios > PIRAMAL PHARMA

PIRAMAL PHARMA
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for PIRAMAL PHARMA
Please provide your vote to see the results

PIRAMAL PHARMA Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 60.74-30.36-23.03-

What is the latest Core EBITDA Growth ratio of PIRAMAL PHARMA ?

The latest Core EBITDA Growth ratio of PIRAMAL PHARMA is 60.74 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar202460.74
Mar2023-30.36
Mar2022-23.03
Mar2021-

How is Core EBITDA Growth of PIRAMAL PHARMA Trending?

Years Core EBITDA Growth % Change
Mar2024 60.74
Positive
Mar2023 -30.36
Negative
Mar2022 -23.03
0
Mar2021 0 -

Other Financial Ratios of PIRAMAL PHARMA


Compare Core EBITDA Growth ratio of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹31,777.0 Cr -0% -9.8% 53.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹416,692.0 Cr -5.3% -7.8% 24.1% Stock Analytics
DIVIS LABORATORIES ₹149,215.0 Cr -3.9% -7.9% 51% Stock Analytics
CIPLA ₹115,000.0 Cr -1.9% -6.9% 3.6% Stock Analytics
DR REDDYS LABORATORIES ₹98,616.4 Cr -8.3% -14.9% 0.8% Stock Analytics
ZYDUS LIFESCIENCES ₹93,841.4 Cr -5.7% -4% 23.6% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

-0%

-9.8%

53.3%

SENSEX

0.2%

-2.2%

7.7%


You may also like the below Video Courses